Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: June 14, 2012
Last updated: November 19, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)